Though the mortality rate has decreased in recent years, pancreatic surgery is still considered as high-risk abdominal surgery, with the morbidity remaining high ranging from 30% to 60%. Patients often recover slowly after pancreatic resection. Therefore, the optimization of perioperative management is very important. The enhanced recovery after surgery (ERAS) program is the most influential optimization of perioperative management. The ERAS protocol for pancreaticoduodenectomy (PD) was proposed in 2012, which has been proved to be safe and feasible by non-randomized studies, with a significantly shortened length of hospital of stay (LOS) with lower morbidity in ERAS group. However, the clinical application of ERAS in pancreatic surgery is still limited due to poor patient compliance or because surgeons have doubts about the modification of some perioperative management measures. Currently, there is substantial heterogeneity in the content of perioperative management after pancreatic surgery.
Controversial exists in many of the perioperative management measures after pancreatic surgery, e.g. nutritional support before pancreatic surgery, preoperative biliary drainage, prophylactic application of somatostatin after surgery, and intraperitoneal drainage management (no drain or early removal of drainage). This Research Topic will provide more evidence to the effectiveness and safety of various perioperative management in pancreatic surgery, thereby helping to identify the optimal management strategies for patients undergoing pancreatic surgery.
We welcome submissions focusing on, but not limited to, the following areas:
• Application of ERAS in pancreatic surgery.
• Preoperative nutritional evaluation and preoperative support for patients undergoing pancreatic resection.
• Pre-operative biliary drainage for obstructive jaundice.
• Prophylactic application of somatostatin after pancreatic surgery.
• Evaluation of prophylactic placement of intra-abdominal drainage in pancreatic surgery.
• Assessment of drain removal after pancreatectomy.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Though the mortality rate has decreased in recent years, pancreatic surgery is still considered as high-risk abdominal surgery, with the morbidity remaining high ranging from 30% to 60%. Patients often recover slowly after pancreatic resection. Therefore, the optimization of perioperative management is very important. The enhanced recovery after surgery (ERAS) program is the most influential optimization of perioperative management. The ERAS protocol for pancreaticoduodenectomy (PD) was proposed in 2012, which has been proved to be safe and feasible by non-randomized studies, with a significantly shortened length of hospital of stay (LOS) with lower morbidity in ERAS group. However, the clinical application of ERAS in pancreatic surgery is still limited due to poor patient compliance or because surgeons have doubts about the modification of some perioperative management measures. Currently, there is substantial heterogeneity in the content of perioperative management after pancreatic surgery.
Controversial exists in many of the perioperative management measures after pancreatic surgery, e.g. nutritional support before pancreatic surgery, preoperative biliary drainage, prophylactic application of somatostatin after surgery, and intraperitoneal drainage management (no drain or early removal of drainage). This Research Topic will provide more evidence to the effectiveness and safety of various perioperative management in pancreatic surgery, thereby helping to identify the optimal management strategies for patients undergoing pancreatic surgery.
We welcome submissions focusing on, but not limited to, the following areas:
• Application of ERAS in pancreatic surgery.
• Preoperative nutritional evaluation and preoperative support for patients undergoing pancreatic resection.
• Pre-operative biliary drainage for obstructive jaundice.
• Prophylactic application of somatostatin after pancreatic surgery.
• Evaluation of prophylactic placement of intra-abdominal drainage in pancreatic surgery.
• Assessment of drain removal after pancreatectomy.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
